Dermatology Clinical Trials - Alan R. Shalita Clinical Research Unit

We are recruiting patients for our active clinical trials. If you are interested in participating or obtaining more information, please contact our Dermatology Research Department at 718-270-2991.

Currently Enrolling


LITE Study- Psoriasis: Home vs. Office Phototherapy (SUNY – Dr. Jakus) 

Ages 12+, 12 weeks of phototherapy, 50% office 50% home device. 


NEW! Arcutis Study (Topical Roflumilast): Adult and Pediatric Atopic Dermatitis (SUNY – Dr. Jakus)

ARQ-151 Cream (Roflumilast) vs placebo, ages 2+, mild-moderate eczema and ≥3% BSA involvement with option to rollover into the open label extension study

NEW! Dermavant Study (Topical Tapinarof): Pediatric Atopic Dermatitis (SUNY – Dr. Jakus) 

Tapinarof Cream 1% (AhR agonist) vs placebo, ages 2 to 18, moderate-severe atopic dermatitis  with option to rollover into the open label extension study


Bakuchiol & Aloe AntiAging Cream (SUNY- Dr. Wei-Li Lee) 

Topical Bakuchiol and green aloe cream BID for fine lines, wrinkles, and hyperpigmentation. Ages 18-70, evidence of UV damage,  

Estee Lauder added benefit of DNA cream and SPF (SUNY- Dr. Wei-Li Lee / Dr. Glick) 

Topical DNA repair cream for possible reversal/repair of sun damage. 


Epidermolysis Bullosa (DEB or JEB) (SUNY- Dr. Glick) 

Topical Thymosin gel, ages 4+ 

Superficial BCC: Red Light PDT for BCC (VA- Dr. Markowitz) 

Ameluz + Red Light PDT, VA patients only, 3mm punch biopsy before and after treatment. 

Enrolling Soon

Tremfaya Psoriatic Arthritis (VA- Dr. Markowitz)

Tremfaya (anti IL-23), 18+, >10% BSA, study drug naive.  

Galderma Study (Injectable Nemolizumab): Peds Atopic Dermatitis   (SUNY – Dr. Jakus)

Nemolizumab (anti IL-31), ages 2-11*, moderate-severe eczema
* enrollment for this age group to begin in October 2022

Contact Information

For Patients:

For more information, please feel free to reach out to us. We are happy to answer any questions you may have. When emailing, please indicate the study title in the subject line: (ie. "PSORIASIS", "ACNE").

For Physicians:

Information on all interested patients should be forwarded to our fellows as soon as possible. Patients should also be given the information below to contact our offices directly.


Jeannette Jakus, MD, MBA
Director of Clinical Trials & Research

Sumer Baroud, MD (Dr. Jakus's studies)
Dermatology Research Fellow- Clinical Trials

Laura Uwakwe MD
Pediatric Dermatology Research Fellow (Dr. Glick's studies)

Tel: 718-270-2991